Technical Documents

Civil Society Statements

Actions in Brazil

 “We decided to file another patent opposition because the monopoly could be extended from 2017 to 2024, if this patent is granted. The granting of undue patents must be avoided to signal that market strategies seeking unlimited monopoly shall not undermine the sustainability of responses to public health needs”. 

            -- Renata Reis, coordinator of the Working Group on Intellectual Property of the Brazilian Network for the Integration of Peoples (GTPI/ Rebrip)

In Brazil, more than 50,000 people currently take lopinavir + ritonavir. The Working Group on Intellectual Property of the Brazilian Network for the Integration of Peoples (GTPI/ Rebrip) filed an opposition to Abbott patent claims on the medicine’s heat-stable form, which are not novel and do not contribute an inventive step.

Actions to Expand Access to Kaletra in Brazil

GTPI supports judicial decision annulling the patent for a HIV/AIDS medicine (links to

Link to press release (November 10, 2011) (em português) from o Grupo de Trabalho Sobre Propriedade Intelectual da Rede Brasiliera pela Integração dos Povos (GTPI/Rebrip)


MSF: Brazilians demand greater access to crucial HIV drug (links to

Working Group on International Property (GTPI) on Brazilian Patent Office's decision to prioritize examination of the patent application related to heat-stable ritonavir and lopinavir/ritonavir - December 15, 2011 (links to

ABIA publishes landscape of patent status and health sanitary registrations for HIV/AIDS treatments in Brazil (jn Portuguese), August 2012

 Essential Action Factsheet- Access to Medicines in Brazil: Interference by the United States, September 21, 2007

Return to the Kaletra Campaign Homepage

Copyright © 2017 Public Citizen. Some rights reserved. Non-commercial use of text and images in which Public Citizen holds the copyright is permitted, with attribution, under the terms and conditions of a Creative Commons License. This Web site is shared by Public Citizen Inc. and Public Citizen Foundation. Learn More about the distinction between these two components of Public Citizen.

Public Citizen, Inc. and Public Citizen Foundation


You can support the fight for greater government and corporate accountability through a donation to either Public Citizen, Inc., or Public Citizen Foundation, Inc.

Public Citizen lobbies Congress and federal agencies to advance Public Citizen’s mission of advancing government and corporate accountability. When you make a contribution to Public Citizen, you become a member of Public Citizen, showing your support and entitling you to benefits such as Public Citizen News. Contributions to Public Citizen are not tax-deductible.

Public Citizen Foundation focuses on research, public education, and litigation in support of our mission. By law, the Foundation can engage in only very limited lobbying. Contributions to Public Citizen Foundation are tax-deductible.